company background image
2348

Dawnrays Pharmaceutical (Holdings) SEHK:2348 Stock Report

Last Price

HK$1.16

Market Cap

HK$1.7b

7D

0%

1Y

-31.8%

Updated

28 Nov, 2022

Data

Company Financials
2348 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends3/6

2348 Stock Overview

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

Dawnrays Pharmaceutical (Holdings) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dawnrays Pharmaceutical (Holdings)
Historical stock prices
Current Share PriceHK$1.16
52 Week HighHK$1.70
52 Week LowHK$0.98
Beta0.88
1 Month Change6.42%
3 Month Change-4.13%
1 Year Change-31.77%
3 Year Change-18.31%
5 Year Change-46.91%
Change since IPO179.52%

Recent News & Updates

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Sep 19
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Recent updates

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Sep 19
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals

Sep 22
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals

Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015

Sep 12
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015

Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015

Aug 29
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015

Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend

Feb 28
Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend

Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?

Feb 07
Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?

Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares

Jan 14
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares

Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Dec 22
Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?

Dec 09
What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?

Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend

Nov 23
Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend

Shareholder Returns

2348HK PharmaceuticalsHK Market
7D0%-6.9%-0.2%
1Y-31.8%-13.7%-24.6%

Return vs Industry: 2348 underperformed the Hong Kong Pharmaceuticals industry which returned -13.7% over the past year.

Return vs Market: 2348 underperformed the Hong Kong Market which returned -24.6% over the past year.

Price Volatility

Is 2348's price volatile compared to industry and market?
2348 volatility
2348 Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement7.6%
Market Average Movement8.0%
10% most volatile stocks in HK Market15.0%
10% least volatile stocks in HK Market3.9%

Stable Share Price: 2348 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 2348's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19951,058Weixian Wuhttps://www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics.

Dawnrays Pharmaceutical (Holdings) Limited Fundamentals Summary

How do Dawnrays Pharmaceutical (Holdings)'s earnings and revenue compare to its market cap?
2348 fundamental statistics
Market CapHK$1.69b
Earnings (TTM)HK$395.91m
Revenue (TTM)HK$1.29b

4.4x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2348 income statement (TTM)
RevenueCN¥1.18b
Cost of RevenueCN¥480.40m
Gross ProfitCN¥699.64m
Other ExpensesCN¥336.45m
EarningsCN¥363.19m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.24
Gross Margin59.29%
Net Profit Margin30.78%
Debt/Equity Ratio1.0%

How did 2348 perform over the long term?

See historical performance and comparison

Dividends

6.6%

Current Dividend Yield

27%

Payout Ratio